Related Experiment Video

Updated: Apr 20, 2026

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

4.1K

miR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3

Fengzhen Huang1, Li Zhang2, Zhe Long2

  • 1Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China; Department of Neurology & Institute of Translational Medicine at University of South China, The First People's Hospital of Chenzhou, Chenzhou, PR China.

FEBS Letters
|December 3, 2014
PubMed

Insights

MicroRNA-25 (miR-25) reduces harmful ataxin-3 protein levels in Machado-Joseph disease (MJD) cells. This finding suggests miR-25 could be a potential therapeutic target for MJD and other polyglutamine diseases.

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuroscience

Background:

  • MicroRNAs (miRNAs) are implicated in the pathology of polyglutamine (polyQ) diseases.
  • Understanding gene regulation in these disorders is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of specific miRNAs in regulating ATXN3 gene expression.
  • To explore the therapeutic potential of miRNA-based interventions in polyQ diseases, specifically Spinocerebellar Ataxia Type 3/Machado-Joseph Disease (SCA3/MJD).

Main Methods:

  • Investigated the interaction between miR-25 and the 3' untranslated region (3'UTR) of ATXN3 mRNA.
  • Assessed the impact of miR-25 on wild-type and mutant ataxin-3 protein levels in cellular models.
  • Evaluated the effects of miR-25 on cell viability, apoptosis, and protein aggregate formation in SCA3/MJD cells.

Main Results:

  • miR-25 directly targets and reduces both wild-type and polyQ-expanded mutant ataxin-3 protein levels.
  • miR-25 enhances cell viability and decreases early apoptosis in SCA3/MJD cells.
  • miR-25 treatment leads to reduced accumulation of mutant ataxin-3 protein aggregates.

Conclusions:

  • miR-25 plays a significant role in the pathogenesis of SCA3/MJD by modulating ataxin-3 levels and aggregation.
  • miR-25 represents a promising therapeutic target for SCA3/MJD and potentially other polyQ diseases.
Keywords:
ATXN3CytotoxicityGene expression regulationNeuronal intranuclear inclusionSpinocerebellar ataxia type 3/Machado–Joseph diseasemiR-25

More Related Videos

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

8.2K
Growth Assays to Assess Polyglutamine Toxicity in Yeast09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

14.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K